• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Sergio Held

Sergio Held

Articles

ARTICLES

Latin America: GE Healthcare acquires main Colombian distributor

Feb. 9, 2015
By Sergio Held

Chilean scientists developing melanoma vaccine for trials in Cuba

Feb. 6, 2015
By Sergio Held
BOGOTA, Colombia – Chilean researchers from the Instituto Milenio en Inmunología e Inmunoterapia (IMII) are developing a vaccine targeting melanoma, as well as vaccines for infectious agents of high impact on public health. IMII said the cancer vaccine will be tested in Cuba.
Read More

Latin America: New Peruvian regulations create questions for device distributors

Jan. 30, 2015
By Sergio Held

Apollo Endosurgery set to launch operations in Costa Rica this year

Jan. 23, 2015
By Sergio Held

Latin America: Establishment Labs to launch second-gen smart breast implants

Jan. 21, 2015
By Sergio Held

Cofepris shakes up Regulatory Market: Mexico deregulates hundreds of medical devices and products

Jan. 15, 2015
By Sergio Held

Mexico issues new regulations for novel drugs, biosimilars

Jan. 9, 2015
By Sergio Held
BOGOTA, Colombia – Mexico's health secretary recently issued new regulations regarding sanitary inspection and approval for imported biotech products. It is hoped by regulators and biotech companies that the new rules, which clarify many previously unclear aspects of the biotech market, will enable foreign companies to operate with greater confidence and ease in the Latin American country.
Read More

Venezuela signs $117M maintenance contract with an Argentina company

Jan. 2, 2015
By Sergio Held

Argentina to expand national immunization schedule, likely boosting GSK, Merck sale

Dec. 30, 2014
By Sergio Held
BOGOTA, Colombia – As of 2015, Argentina will add three vaccines to its already significant immunization schedule. Vaccines for varicella zoster virus (chickenpox), rotaviruses and Neisseria meningitidis will be added to the country´s national immunization program (NIP).
Read More

High hopes for the MDSAP certification pilot program

Dec. 29, 2014
By Sergio Held
View All Articles by Sergio Held

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 13, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 13, 2025.
  • AI generated, 3D rendering of protein degradation

    AACR 2025: Induced proximity strategy, beyond degraders

    BioWorld
    Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 13, 2025
  • Businessman and IPO virtual screen

    Three med-tech IPOs on the horizon

    BioWorld MedTech
    April may not have brought rain to med-tech, but tariffs and financial uncertainty certainly dampened the enthusiasm for IPOs. With those clouds lifting, three...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe